NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03441113,Extended Access of Momelotinib in Adults With Myelofibrosis,https://clinicaltrials.gov/study/NCT03441113,,ACTIVE_NOT_RECRUITING,"The primary objective of this study is to provide extended access and assess long-term safety of momelotinib (MMB) in participants with primary myelofibrosis (PMF) or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (Post-PV/ET MF) enrolled in studies GS-US-352-0101 (NCT01969838), GS-US-352-1214 (NCT02101268), GS-US-352-1154 (NCT02124746), SRA-MMB-301 who are currently receiving treatment with MMB (available as 50mg,100 mg, 150 mg and 200 mg tablets) and have not experienced progression of disease. The secondary objective is to assess overall survival (OS) and leukemia free survival (LFS) in all subjects.",NO,Neoplasms|Post-polycythemia Vera Myelofibrosis (Post-PV MF)|Primary Myelofibrosis (PMF)|Post-essential Thrombocythemia Myelofibrosis (Post-ET MF),DRUG: MMB,"Number of Participants Who Had Access to, and Received the Intervention, Participants will be assessed every 12 weeks until discontinuation. Participation in this extended access study has been an average of approximately 8 months.",,,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE2,237,INDUSTRY,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,219627|2017-004350-42|SRA-MMB-4365|219627,2018-05-03,2026-12-31,2026-12-31,2018-02-22,,2024-05-16,"IC Irvine Health, Orange, California, 92868, United States|GSK Investigational Site, Stanford, California, 94305-5821, United States|Stanford Hospital and Clinics, Stanford, California, 94305, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|GSK Investigational Site, Jacksonville, Florida, 32224, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Northwest Oncology & Hematology - Rolling Meadows, Rolling Meadows, Illinois, 60008, United States|GSK Investigational Site, Baltimore, Maryland, 21229-5299, United States|Saint Agnes Hospital, Baltimore, Maryland, 21229, United States|Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, 02215, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Rochester, Minnesota, 55905, United States|Mayo Clinic - Department of Hematology, Rochester, Minnesota, 55905, United States|Washington University School of Medicine Siteman Cancer Center, Saint Louis, Missouri, 63110, United States|GSK Investigational Site, Saint Louis, Missouri, 63130, United States|GSK Investigational Site, Hackensack, New Jersey, 07601, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|GSK Investigational Site, Bronx, New York, 10467, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|GSK Investigational Site, Cleveland, Ohio, 44195, United States|GSK Investigational Site, Portland, Oregon, 97239, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53226, United States|Mayo Clinic Building - Phoenix, Milwaukee, Wisconsin, 53226, United States|Icon Cancer Care Wesley, Hyde Park, Queensland, 4812, Australia|GSK Investigational Site, South Brisbane, Queensland, 4101, Australia|Flinders Medical Centre, Adelaide, South Australia, 5000, Australia|GSK Investigational Site, Adelaide, South Australia, 5000, Australia|GSK Investigational Site, Frankston, Victoria, 31 99, Australia|Frankston Hospital, Frankston, Victoria, 3199, Australia|GSK Investigational Site, Melbourne, Victoria, 3004, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|GSK Investigational Site, Parkville, Victoria, 3050, Australia|Peter MacCallum Cancer Centre, Parkville, Victoria, 3050, Australia|GSK Investigational Site, Perth, Western Australia, 6000, Australia|Royal Perth Hospital, Perth, Western Australia, 6160, Australia|Ordensklinikum Linz Elisabethinen, Linz, Upper Austria, 4020, Austria|Medizinische Universität Wien, Wien, Vienna, 1090, Austria|GSK Investigational Site, Linz, 4020, Austria|GSK Investigational Site, Wien, 1090, Austria|Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan, Brugge, West-Vlaanderen, 8000, Belgium|GSK Investigational Site, Antwerpen, 2060, Belgium|Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, 2060, Belgium|GSK Investigational Site, Brugge, 8000, Belgium|GSK Investigational Site, Leuven, 3000, Belgium|Universitaire Ziekenhuis Leuven, Leuven, 3000, Belgium|Centre Hospitalier Universitaire de Liège Site Sart Tilman, Liège, 4000, Belgium|GSK Investigational Site, Liège, 4000, Belgium|GSK Investigational Site, Pleven, 5800, Bulgaria|UMHAT Dr. Georgi Stranski EAD, Pleven, 5800, Bulgaria|GSK Investigational Site, Ruse, 7002, Bulgaria|Multiprofile Hospital for Active Treatment Ruse, Ruse, 7002, Bulgaria|GSK Investigational Site, Sofia, 01431, Bulgaria|National Specialized Hospital for Active Treatment of Haematologic Diseases, Sofia, 1431, Bulgaria|University Multiprofile Hospital for Active Treatment St. Ivan Rilski, Sofia, 1431, Bulgaria|GSK Investigational Site, Sofia, 1756, Bulgaria|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H3H 2R9, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|Research Institute of the McGill University Health Centre, Montréal, Quebec, H3H 2R9, Canada|Sir Mortimer B. Davis Jewish General Hospital, Montréal, H3T 1E2, Canada|Princess Margaret Cancer Centre, Toronto, M5G 2M9, Canada|Aalborg University Hospital, Aalborg, 9000, Denmark|Gentofte Hospital, Herlev, 2730, Denmark|GSK Investigational Site, Koebenhavn, 2100, Denmark|GSK Investigational Site, Ålborg, 9000, Denmark|Hopital Saint-Louis, Paris, ILE-De-FRANCE, 75475, France|Centre Hospitalier Le Mans, Le Mans, Pays De La Loire, 72037, France|GSK Investigational Site, Le Mans Cedex, 72037, France|CHRU Huriez Lille, Lille Cedex, 59020, France|GSK Investigational Site, Marseille CEDEX 9, 13273, France|Institut Paoli Calmettes, Marseille, 13273, France|GSK Investigational Site, Paris cedex 10, 75475, France|GSK Investigational Site, Pessac cedex, 33604, France|Hôpital Haut-Lévêque, Pessac Cedex, 33604, France|Centre Hospitalier Lyon Sud, Pierre Bénite Cedex, 69495, France|GSK Investigational Site, Pierre-Bénite cedex, 69495, France|GSK Investigational Site, Toulouse Cedex 9, 31059, France|Institut Universitaire du Cancer, Toulouse Cedex 9, 31059, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, 79106, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, 52074, Germany|Universitätsklinikum Aachen, Aachen, Nordrhein-Westfalen, 52074, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50937, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, 55131, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, 06120, Germany|Universitätsklinikum Halle, Halle, Sachsen-Anhalt, 06120, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Leipzig, Sachsen, 04103, Germany|Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, 23538, Germany|University Hospital of Cologne, Cologne, 50937, Germany|Universitätsklinikum Dresden, Dresden, 01307, Germany|Universitätsklinikum Leipzig, Leipzig, 04103, Germany|Johannes Gutenberg-Universität Mainz, Mainz, 55131, Germany|Petz Aladár Egyetemi Oktató Kórház - Győr, Győr, Gyor-Moson-Sopron, 9023, Hungary|Szent Borbála Kórház, Tatabánya, Komárom-Esztergom, 2800, Hungary|Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Budapest, Pest, 1097, Hungary|Szabolcs-Szatmár-Bereg Megyei Kórházak És Egyetemi Oktatókórház, Nyíregyháza, Szabolcs-Szatmár-Bereg, 4400, Hungary|GSK Investigational Site, Budapest, 1083, Hungary|Semmelweis Egyetem I. sz. Belgyogyaszati Klinika, Hematologia, Budapest, 1083, Hungary|GSK Investigational Site, Budapest, 1097, Hungary|Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Haematologiai Tanszek, Debrecen, 4032, Hungary|GSK Investigational Site, Debrecen, 4032, Hungary|GSK Investigational Site, Győr, 9024, Hungary|GSK Investigational Site, Kaposvár, 7400, Hungary|Somogy Megyei Kaposi Mor Oktató Kórház, Kaposvár, 7400, Hungary|GSK Investigational Site, Nyiregyhaza, 4400, Hungary|GSK Investigational Site, Tatabánya, 2800, Hungary|GSK Investigational Site, Afula, 18101, Israel|Emek Medical Center, Afula, 1834111, Israel|Barzilai Medical Center, Hematology Institute, Ashkelon, 78278, Israel|GSK Investigational Site, Ashkelton, 7830604, Israel|Carmel Medical Center, Haifa, 3436212, Israel|GSK Investigational Site, Haifa, 3436212, Israel|GSK Investigational Site, Jerusalem, 9112001, Israel|Hadassh Medical Organization, Jerusalem, 91120, Israel|Meir Medical Center, Kfar Saba, 4428164, Israel|GSK Investigational Site, Kfar Saba, 44281, Israel|GSK Investigational Site, Rionero In Vulture (Pz), Basilicata, 85028, Italy|GSK Investigational Site, Napoli, Campania, 80131, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, 40138, Italy|Azienda Ospedaliero - Universitaria Careggi, Firenze, Florence, 50134, Italy|GSK Investigational Site, Genova, Liguria, 16132, Italy|GSK Investigational Site, Milano, Lombardia, 20122, Italy|GSK Investigational Site, Monza (MB), Lombardia, 20900, Italy|Azienda Socio Sanitaria Territoriale Monza - Ospedale San Gerardo, Monza, Monza E Brianza, 20900, Italy|Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Pesaro E Urbino, 61121, Italy|GSK Investigational Site, Torino, Piemonte, 10126, Italy|GSK Investigational Site, Firenze, Toscana, 50134, Italy|GSK Investigational Site, Torino, Trentino-Alto Adige, 10128, Italy|Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino, Turin, 10126, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Turin, 10128, Italy|GSK Investigational Site, Verona, Veneto, 37134, Italy|Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola-Malpighi, Bologna, 40138, Italy|Azienda Ospedaliera Universitaria San Martino, Genova, 16132, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Azienda Ospedaliera Universitaria Federico II, Napoli, 80131, Italy|GSK Investigational Site, Pesaro, 61122, Italy|IRCCS Centro di Riferimento Oncologico di Basilicata, Potenza, 85028, Italy|GSK Investigational Site, Roma, 00161, Italy|Umberto I - Policlinico di Roma, Roma, 00161, Italy|Ospedale Policlinico Giambattista Rossi Borgo Roma, Verona, 37134, Italy|Inje University Haeundae Paik Hospital, Busan, Busan Gwang'yeogsi [Pusan-Kwangyokshi], 48108, Korea, Republic of|Kyungpook National University Hospital, Daegu, Daegu Gwang'yeogsi, 41944, Korea, Republic of|Severance Hospital, Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], 03722, Korea, Republic of|GSK Investigational Site, Busan, 48108, Korea, Republic of|GSK Investigational Site, Daegu, 700-721, Korea, Republic of|GSK Investigational Site, Seoul, 03080, Korea, Republic of|GSK Investigational Site, Seoul, 03722, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Catholic University of Korea Seoul Saint Mary's Hospital, Seoul, 06591, Korea, Republic of|GSK Investigational Site, Seoul, 135-710, Korea, Republic of|GSK Investigational Site, Seoul, 137-701, Korea, Republic of|Seoul National University Hospital, Seoul, 3080, Korea, Republic of|Maastricht University Medical Centre, Maastricht, Limburg, 6229 HX, Netherlands|GSK Investigational Site, Maastricht, 6229 ER, Netherlands|Szpital Wojewódzki w Opolu, Opole, Opolskie, 45-064, Poland|Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Podkarpacki, 36-200, Poland|Uniwersyteckie Centrum Kliniczne, Gdańsk, Pomoskie, 80-952, Poland|GSK Investigational Site, Brzozow, 36-200, Poland|GSK Investigational Site, Chorzow, 41-500, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich, Chorzów, 41-500, Poland|GSK Investigational Site, Gdansk, 80-214, Poland|GSK Investigational Site, Krakow, 31-501, Poland|GSK Investigational Site, Lublin, 20-081, Poland|Samodzielny Publiczny Szpital Kliniczny nr 1 w Lub, Lublin, 20-081, Poland|Szpital Uniwersytecki w Krakowie, Oddzial Kliniczny Hematologii, Małogoskie, 31-501, Poland|GSK Investigational Site, Opole, 45-061, Poland|GSK Investigational Site, Poznań, 60-631, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA w Poznaniu im. Ledwika Bierkowskiego, Poznań, 60-631, Poland|GSK Investigational Site, Brasov, 500152, Romania|Policlinica de Diagnostic Rapid SA, Braşov, 500152, Romania|GSK Investigational Site, Bucharest, 022328, Romania|GSK Investigational Site, Bucharest, 030171, Romania|Spitalul Clinic Coltea, Bucuresti, 030171, Romania|Institutul Clinic Fundeni, Bucuresti, 22328, Romania|GSK Investigational Site, Cluj-Napoca, 400124, Romania|Institutul Oncologic Prof. Dr. Ion Chiricuţă, Cluj-Napoca, 400124, Romania|GSK Investigational Site, Craiova, 200143, Romania|Spitalul Clinic Municipal Filantropia Craiova, Craiova, 200143, Romania|GSK Investigational Site, Iasi, 700111, Romania|Institutul Regional De Oncologie IASI, Iasi, 700483, Romania|GSK Investigational Site, Singapore, 169608, Singapore|Singapore General Hospital, Singapore, 169608, Singapore|GSK Investigational Site, Singapore, 188770, Singapore|Raffles Hospital, Singapore, 188770, Singapore|Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|GSK Investigational Site, Barcelona, 08003, Spain|Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, 08003, Spain|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 08916, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 8035, Spain|GSK Investigational Site, Madrid, 28034, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|GSK Investigational Site, Madrid, 28041, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Madrid, 28222, Spain|GSK Investigational Site, Majadahonda (Madrid), 28222, Spain|Clínica Universidad de Navarra, Pamplona, 31008, Spain|GSK Investigational Site, Pamplona, 31008, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|Hospital de Día Quirónsalud Zaragoza, Zaragoza, 50012, Spain|GSK Investigational Site, Kaohsiung, 807, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|GSK Investigational Site, Kaohsiung, 833, Taiwan|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 88301, Taiwan|GSK Investigational Site, Taipei, 100, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Chang Gung Memorial Hospital - Linkou Branch, Taoyuan, 333, Taiwan|GSK Investigational Site, Taoyuan, 333, Taiwan|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, England, BS2 8ED, United Kingdom|GSK Investigational Site, Airdrie, Lanarkshire, ML6 0JS, United Kingdom|NHS Lanarkshire, Airdrie, Scotland, ML6 0JS, United Kingdom|GSK Investigational Site, Bristol, BS2 8ED, United Kingdom|GSK Investigational Site, Cardiff, CF14 4XW, United Kingdom|University Hospital of Wales, Cardiff, CF14 4XW, United Kingdom|GSK Investigational Site, London, W12 0HS, United Kingdom|Imperial College Healthcare NHS Trust, London, W12 ONN, United Kingdom|GSK Investigational Site, Oxford., OX3 7LE, United Kingdom|Oxford University Hospitals NHS Trust, Oxford, OX3 7LJ, United Kingdom",
